Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 4,062,794 6.000% | 970,983 (+31.40%) | Filing History |
| 2022-01-24 08:40 am Sale | 2022-01-21 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 6,818,422 10.007% | -510,164 (-6.96%) | Filing History |
| 2021-06-10 1:14 pm Purchase | 2021-05-31 | 13G | Beam Therapeutics Inc. BEAM | ARK Investment Management LLC | 6,306,549 10.080% | 6,306,549 (New Position) | Filing History |
| 2021-04-09 6:02 pm Sale | 2021-03-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 3,091,811 5.000% | -67,699 (-2.14%) | Filing History |
| 2021-02-16 4:18 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | HHLR ADVISORS LTD. | 2,966,403 5.100% | 2,966,403 (New Position) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | Redmile Group, LLC | 3,778,262 6.500% | 3,778,262 (New Position) | Filing History |
| 2021-02-08 10:17 am Purchase | 2021-02-05 | 13G | Beam Therapeutics Inc. BEAM | FMR LLC | 7,328,586 12.642% | 356,674 (+5.12%) | Filing History |
| 2021-02-05 06:06 am Purchase | 2020-02-06 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,354,641 5.700% | 3,354,641 (New Position) | Filing History |
| 2021-02-02 4:13 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | ARCH Venture Fund IX, L.P. | 8,243,039 13.500% | 8,243,039 (New Position) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | BlackRock Inc. BLK | 3,159,510 5.500% | 3,159,510 (New Position) | Filing History |